Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Actualites Pharmaceutiques is Scopus-indexed (Q4, CiteScore 0.2), WoS ESCI. It is covered by India's One Nation One Subscription scheme for reading access. Published by Elsevier Masson s.r.l..
Checked against the index lists dated .
ISSN 0515-3700Verify ISSN ↗
Publisher: Elsevier Masson s.r.l.
Cost to publish: About US$3,000 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmacology (medical) | 263 / 278 | 5th | Q4 |
| Pharmacology | 312 / 328 | 5th | Q4 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1996–present (also 1963, 1961), best quartile Q4, CiteScore 0.2.
Actualites Pharmaceutiques is Q4 in Pharmacology (medical) (rank 263 of 278) and Q4 in Pharmacology (rank 312 of 328), by CiteScore 2025.
Actualites Pharmaceutiques is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 0.2, which places it in quartile Q4 at the 5th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.170, quartile Q4, with an H-index of 7.
The publisher lists an article processing charge of about US$3,000 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Actualites Pharmaceutiques is published by Elsevier Masson s.r.l. Its ISSN is 0515-3700.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Emerging Sources Citation Index.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Actualites Pharmaceutiques has an h-index of 9 and a 2-year mean of 0.03 citations per paper (OpenAlex). Its Scopus CiteScore is 0.2, quartile Q4. On 2-year citations it ranks #247 of 271 Scopus journals in Pharmacology (medical).
Actualites Pharmaceutiques published 236 papers in 2025; its busiest recent year was 2023 with 267. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 30 research articles (2026), authors are most often from France (96.7%) and Morocco (3.3%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.